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Introduction
Arrestins consist of a family of four proteins, including the ubiquitously expressed b-arrestin 1 and b-arrestin 2 (also known as arrestin 2 and arrestin 3), in addition to two visual arrestins (arrestin 1 and arrestin 4) that are expressed exclusively in the retinae of mammals (Bruns et al., 2006) . b-Arrestin 1 and b-arrestin 2, the classical regulators of G-protein-coupled receptors (GPCRs), not only negatively regulate GPCR-mediated signaling, but also serve as scaffolds and adapters in numerous crucial signal transduction pathways such as Wnt, TGF-b, Smo, NF-jB, p53, and MAPK cascades (Fraser, 2008; Morishita et al., 2007; Ruiz-Gó mez et al., 2007; Wang et al., 2002; Wang and Malbon, 2003) . This suggests b-arrestin 1/2 play important roles in the developmental process. b-Arrestin 1 or b-arrestin 2 knockout mice appear normal, which can potentially be explained by the homologous structures and compensatory effects of these two genes (Han et al., 2001; Hirsch et al., 1999; Pierce and Lefkowitz, 2001) . So b-arrestin 1/2 double knockout mice (Arrb1
) were generated for comparison. At birth, the wild type and heterozygous pups (Arrb1 
Arrb2
À/À neonates died due to respiratory distress. Microarray data showed significant downregulation of Nr3c1 (Glucocorticoid receptor, GR) transcripts in Arrb1 À/À Arrb2 À/À E18.5 lungs (Zhang et al., 2010) .
However, the roles of GR in b-arrestin trafficking and signaling are yet to be elucidated. GR is a ubiquitously expressed and ligand-activated transcription factor. After glucocorticoid binding, GR translocates to the nucleus and activates the transcription of target genes which carry the specific GR binding sites. This initiates many physiological and developmental processes, including final 0925-4773/$ -see front matter Ó 2011 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2011.07.003 lung maturation, hepatic gluconeogenesis, and mobilization of amino acids and fatty acids, etc. (Chinoy et al., 2001; McKenna and O'Malley, 2002; Newton, 2000) . One of the essential processes of the lung prenatal maturation is synthesis and secretion of surfactant proteins into the air space (Xu et al., 2008) . Numerous biochemical studies in preterm rabbits, rats, mice, and sheep have shown that, via the intracellular GR, glucocorticoids partially regulate the production of lung surfactant, predominantly by promoting expression of the type II cell-specific surfactant proteins SP-A, SP-B, and SP-C (Mendelson, 2000) . The use of prenatal glucocorticoids for the prevention of respiratory distress syndrome (RDS) emphasizes the importance and utility of GR in regulating gene transcription during lung maturation. GR shows a developmental increase in expression in normal lungs, which coincides with the appearance of surfactant proteins, also supporting its role in lung maturation during late gestational stages (Chinoy et al., 2001) .
Hepatic gluconeogenesis is an important process in the adjustment of the hepatic glucose production by synthesizing glucose from precursors such as lactate, gluconeogenic amino acids, and glycerol (Cherrington, 1999; Nordlie et al., 1999) . Glucocorticoids, via binding to the intracellular GR, increase cellular concentrations of enzymes and substrates for gluconeogenesis, ultimately leading to increased hepatic glucose production in the liver (Opherk et al., 2004; Watts et al., 2005) . Upon activation, GR results in the transcriptional activation of GC-regulated enzymes such as tyrosine aminotransferase (TAT) and serine dehydratase (SDH) (Kellendonk et al., 1999; Stafford et al., 2001) . In hepatic gluconeogenesis, TAT and SDH are crucial enzymes that help catabolize amino acids for import into the gluconeogenic pathway, maintaining glucose homeostasis in the liver (Cole et al., 1995) .
The action of GR in the transcriptional regulation of surfactant proteins in the lung and gluconeogenic enzymes in the liver has attracted intense interest in its role in modulating lung and liver development in b-arrestin 1/2 double mutants. This study aimed to clarify the role of GR in the b-arrestin signaling pathway by investigating the lung and liver development in b-arrestin 1/2 dual-null mice using a series of histological and molecular techniques. Our results indicated that, despite severe pulmonary hypoplasia and hepatic impairment with significant decreases in GR expression in lung and liver tissue of Arrb1
À/À neonates, no significant changes in GR expression following modulation of b-arrestin 1/2 expression in vitro suggest an indirect regulatory relationship between GR and the b-arrestin signaling pathway.
Results

2.1.
Depletion of b-arrestin 1/2 led to severe deficiencies in lung and liver development
Arrb1
À/À and Arrb2 À/À mice were bred to generate
) neonates died within a few hours of birth in accordance with our previous report (Zhang et al., 2010) . Dramatic morphologic defects in lung and liver development were revealed by histological staining with hematoxylin and eosin (H&E). As depicted in Fig. 1E and F, Arrb1
mice presented severe alveolar deficiency and obvious thickening of the mesenchyme in contrast to normal formation of alveoli and thinning of mesenchyme in the lungs of wild type neonates, which indicated a severe pulmonary immaturity in b-arrestin 1/2 dual-null mice. 
Arrb2
À/À mice. As shown in Fig. 1A (Fig. 1C) . In contrast, hepatocytes with irregular and disrupted nuclei were randomly dispersed in the lobules of Arrb1 (Fig. 1D ).
2.2.
Deletion of b-arrestin 1/2 resulted in decreased glucocorticoid receptor expression in lung and liver Western blot analysis confirmed the decrease of GR protein levels in b-arrestin 1/2 dual-null lungs of 18.5 day embryos (E18.5) ( Fig. 2A) . Detectable morphological defects were identified in hepatocytes in Arrb1
livers. Western blot analysis also confirmed the presence of b-arrestin 1/2 expression in liver tissue of wild type E18.5 embryos, although expression was absent from Arrb1 showed GR protein levels were dramatically decreased in barrestin 1/2 dual-null livers at E18.5 in comparison to wild type embryos (Fig. 2B ).
Detection of GR expression in type II pneumocytes of distal lung
The results of this study confirmed that GR expression was decreased in the lungs of b-arrestin 1/2 double knockout mice (Fig. 2A) . The expression patterns of b-arrestins and GR in type II pneumocytes of embryonic lungs during late gestational stages were investigated to further elucidate the signaling collaboration between these proteins.
It has been reported that b-arrestin 1/2 staining is detected in tracheal and bronchiolar epithelial cells at E12.5, and is intensified in the alveolar type II cells of the distal lungs at E18.5 (Zhang et al., 2010) . Therefore, the GR expression in the alveolar type II cells was examined by immunofluorescence using anti-TTF-1 (Thyroid Transcription Factor-1) and anti-GR antibodies. TTF-1, a marker for the alveolar type II cells, shows restricted expression to type II pneumocytes in peripheral lung saccules (Stahlman et al., 1996) . Immunostaining of GR (green) and TTF-1 (red) with nuclear 4 0 6-diamidino-2-phenylindole (DAPI, blue) counterstaining in E18.5 lung sections was shown in Fig. 3A -C. These images were merged in Fig. 3D . GR expression was clearly detected in the nuclei of type II pneumocytes with co-expression of b-arrestins and GR in the alveolar type II cells of the distal lungs.
2.4.
Inhibition of b-arrestin 1/2 reduced production of hepatic glucose and expression of gluconeogenic enzymes Studies have revealed that GCs improve hepatic glucose production by increasing the concentrations of enzymes and substrates for gluconeogenesis via a GR mediated mechanism (Watts et al., 2005) . In this study, GR protein levels were shown to be dramatically reduced in E18.5 double knockout livers (Fig. 2B) , suggesting that the hepatic glucose output was influenced by the absence of b-arrestins. Therefore, E18.5 liver sections were stained with periodic acid-Schiff (PAS) to assess intracellular glycogen in hepatocytes. Significantly lower positive PAS staining was observed in hepatocytes of Arrb1
Arrb2
À/À liver compared with wild type embryos (Fig. 4A) . It has known that TAT and SDH are key gluconeogenic enzymes in hepatic gluconeogenesis (Kellendonk et al., 1999; Stafford et al., 2001) . Therefore, quantitative RT-PCR was performed to monitor the overall mRNA levels of these two gluconeogenic enzymes in wild type and Arrb1 À/À Arrb2 À/À liver at E18.5. Expression of GR mRNA was found to be significantly reduced in Arrb1 (Fig. 4B) , consistent with
Western blot analysis (Fig. 2B) . Furthermore, mRNA levels of two key gluconeogenic enzymes, TAT and SDH, were noticeably reduced in Arrb1 À/À Arrb2 À/À liver compared with the wild type (Fig. 4B) .
GR expression was not affected by modulation of b-arrestin 1 and b-arrestin 2 expression in vitro
To further corroborate the regulatory roles of GR in the b-arrestin signaling pathway in vitro, MLE-12 lung epithelial cells were infected with recombinant adenovirus expressing b-arrestin 1 or b-arrestin 2. The MLE-12 cell line was established from murine pulmonary tumors, in which lung surfactant proteins B and C were detected (Wikenheiser et al., 1993) . Adenoviral vectors encoding GFP alone were used in order to identify non-specific viral effects. Quantitative RT-PCR analysis showed that infection with either b-arrestin 1 or b-arrestin 2 adenovirus increased b-arrestin1 or b-arrestin2 but not GR mRNA levels compared to those detected in cells infected with the control adenoviral vector expressing GFP alone (Fig. 5A ). In addition, MLE-12 cells were infected with recombinant lentivirus encoding small inhibitory RNA (siRNA) directed against b-arrestin 1 or b-arrestin 2. Lentiviral vectors encoding GFP alone served as the control lentivirus. Levels of b-arrestin 1 or b-arrestin 2 mRNA in MLE-12 cells infected by b-arrestin 1 or b-arrestin 2 lentiviruses were dramatically decreased compared to those of cells infected by the control lentivirus (Fig. 5B) . However, GR mRNA levels in MLE-12 cells were not altered either by b-arrestin 1 or b-arrestin 2 lentiviral infection alone or in combination (Fig. 5B) .
This observation was further substantiated by investigation of the effects associated with modulation of b-arrestin 1 or b-arrestin 2 expression on GR protein levels in the Hepa 1-6 hepatocyte cell line. Infection of recombinant adenovirus expressing b-arrestin 1 or b-arrestin 2 led to a marked increase in b-arrestin protein levels in Hepa 1-6 cells, although GR proteins were expressed at levels comparable with those in cells infected by control adenovirus (Fig. 6A) . In addition, expression of b-arrestin 1 and b-arrestin 2 proteins was reduced in Hepa 1-6 cells infected by recombinant lentivirus, while the overall abundance of GR did not change (Fig. 6B) .
Discussion
The results of this study provide direct evidence of the critical role of b-arrestin 1 and b-arrestin 2 in murine lung and liver development. In accordance with previously reported findings (Zhang et al., 2010) , deletion of b-arrestin 1 and b-arrestin 2 resulted in death of neonates due to pulmonary immaturity. Severe alveolar deficiency and obvious thickening of the mesenchyme were observed in these animals, indicating disturbance of the morphological maturation of the fetal mouse lung. It has been reported that b-arrestin 1 and b-arrestin 2 are widely expressed throughout the body (Attramadal et al., 1992) . Liver expression of b-arrestin 1 and b-arrestin 2 was confirmed in this study. Furthermore, the embryonic livers of b-arrestin 1/2-deficient mice showed randomly dispersed hepatocytes in the lobules, together with irregular and disrupted nuclei compared with those of the wild type mice. This suggests a positive regulatory role for b-arrestin 1 and b-arrestin 2 in liver development. Collectively, the data provide novel molecular evidence of a previously unrecognized contribution of b-arrestin 1 and b-arrestin 2 to embryonic lung and liver development, particularly during the terminal sac stage.
Notably, signaling by the GR and its putative downstream family have been shown to play important roles, not only in the process of lung maturation through promoting expression of type II cell-specific surfactant proteins, but also in the regulation of hepatic glucose production by activation of hepatic enzymes (Chinoy et al., 2001; Mendelson, 2000; Watts et al., 2005) . It has been reported previously that Nr3c1 (GR) is significantly downregulated in Arrb1 À/À Arrb2 À/À lungs, compared with wild type controls (Zhang et al., 2010) . In this study, GR expression levels were significantly decreased in Arrb1 À/À Arrb2 À/À lung and liver tissues, implicating decreased GR expression in the regulation of the b-arrestin signaling pathway during lung and liver development. Elegant experiments have revealed that homozygous GR-deficient mice exhibit severe lung atelectasis and decreased levels of surfactant markers SP-A and SP-C, eventually resulting in neonatal death due to respiratory failure and delayed lung maturation (Cole et al., 1995; Cole et al., 2004; Nemati et al., 2008) . As reported previously, the embryonic lungs of Arrb1
Arrb2
À/À mice showed obviously reduced cytoplasmic lamellar bodies, dispersed cytoplasmic glycogen, and decreased production of surfactant proteins, indicating b-arrestin 1/2 were involved in the maturation of alveolar type II cells (Zhang et al., 2010) . Similarities in the phenotype of lung immaturity observed between Arrb1 À/À Arrb2 À/À mice and GR À/À mice supports the hypothesis that loss of b-arrestin 1 and 2 activity influences lung maturation, and that this effect is mediated in part by inhibition of GR expression. Furthermore, b-arrestin 1/2 and GR were both detected in type II pneumocytes of embryonic lungs during late gestational stages, thus indicating the involvement of GR in b-arrestin 1/2 signaling pathways in lung maturation. However, further investigation is required to identify the specific mechanisms involved. The principal mechanisms of gluconeogenesis that regulate hepatic glucose output are dependent on the concentrations of the available glucogenic enzymes (Watts et al., 2005) . PAS staining of E18.5 liver sections showed an obvious reduction of intracellular glycogen in hepatocytes of Arrb1
À/À mice, indicating that activation of gluconeogenesis was impaired in the double knockout livers. The mRNA levels of TAT and SDH, enzymes important for gluconeogenesis, and known to be regulated by glucocorticoids, were also dramatically reduced in embryonic liver of b-arrestin 1/2-deficient mice. These data showed a critical requirement for glucocorticoids and their receptors in the b-arrestin 1 and 2 signaling pathway during liver development. Meanwhile, GR À/À mice show a marked decrease in TAT and SDH mRNA levels (Cole et al., 1995; Kellendonk et al., 1999) . Similar reduction in the expression of gluconeogenic enzymes was observed in Arrb1 À/À Arrb2 À/À mice and GR À/À mice, suggesting that the disturbance in liver development associated with deletion of b-arrestin 1/2 is partially mediated by decreased GR expression. The results of this study showed greatly reduced GR expression levels in lung and liver tissues of Arrb1
À/À mice. A simultaneous alteration in GR protein levels was also detected in gut tissues of Arrb1
(data not shown). These observations suggest that GR might be a potential downstream effector involved in b-arrestinsmediated signaling pathway during development. However, no obvious changes in GR expression were detected following modulation of b-arrestin 1 or b-arrestin 2 in MLE-12 and Hepa 1-6 cell lines. Studies in vivo identify homone-dependent downregulation of GR is associated with chronic hormone treatment in most tissues (Bellingham et al., 1992) . The level of GCs is tightly controlled by the hypothalamus-pituitaryadrenal axis (HPA) (Sooy et al., 2010) . The b-arrestins are ubiquitously expressed outside the retina, but are predominantly localized in neuronal tissues (Attramadal et al., 1992) . Therefore, it can be hypothesized that deletion of b-arrestins leads to impairment of neuronal tissues such as the hypothalamus, thus altering GC secretion, and ultimately, affected GR expression in most tissues. However, further studies are required to identify specific mechanisms involved in this process. Moreover, previous data found from the microarray analysis that 1329 genes in the lungs of Arrb1
À/À mice were either up-regulated or down-regulated more than 2 folds, including genes regulating lung development, lipid metabolism and transporter activity, glycogen metabolism and biosynthesis, inflammatory and immune response, cell proliferation and regulation of transcription (Zhang et al., 2010) . Pathway analysis also showed that a significant proportion of the genes involved in cell cycle and TGFb/BMP signal pathway were significantly increased or decreased in the lungs of b-arrestin 1/2 double knockout (Zhang et al., 2010) . Therefore, the decrease in GR levels might be only responsible for part of the phenotypes, and more detailed studies will be needed to ascertain in Arrb1
Experimental procedures
Mice and histopathology
Arrb1 À/À and Arrb2 À/À mice on a C57BL/6 background were intercrossed to generate Arrb1
mice. Genotypes were analyzed by PCR and further confirmed by western blots as previously described (Zhang et al., 2010) . Mouse embryos were harvested from timed pregnant females. At least five animals for each genotype were used in each experiment. The use of mouse embryos in this study was ethically approved by the Ethical Committee of Fujian Normal University. Embryos were washed in phosphate buffered saline (PBS), and dissected lungs were fixed by overnight by immersion in PBS with 4% paraformaldehyde (PFA, pH 7.4) at 4°C. The specimens were dehydrated in a graded ethanol series and embedded in paraffin. Sections (6 lm) were prepared for histopathology staining with hematoxylin and eosin (H&E).
Immunofluorescence
Lung tissues were fixed in PBS with 4% PFA (pH 7.4) at 4°C overnight, then cryoprotected with 30% sucrose at 4°C overnight. Frozen sections were prepared on dry ice from samples embedded in O.C.T. Compound. Tissue sections (10 lm) were incubated with the following primary antibodies: GR (rabbit anti-mouse polyclonal antibody, 1:100; Santa Cruz, USA) and TTF-1 (mouse monoclonal antibody, 1:100; Thermo Fisher Scientific, USA) overnight at 4°C. Sections were then incubated with appropriate secondary antibodies: FITC-conjugated goat anti-rabbit and TRITC-conjugated goat anti-mouse (1:1000; Upstate, USA) for 1 h, followed by incubation with DAPI (2 lg/ml) for 5 min at room temperature. Images were acquired by confocal laser fluorescence microscopy (Leica, German). Green, red and blue fluorescent signals were then merged.
Western blotting
Tissue protein extracts, prepared using a Tissue Protein Extraction kit (KangChen Bio-Tech, China), were analyzed by Western blot using rabbit anti-human b-arrestin A2CT (1:1000, gift from Dr. Robert J. Lefkowitz, Duke University Medical Center), rabbit anti-mouse GR (1:1000, Santa Cruz, USA), and rabbit anti-human b-actin (1:3000, Sigma, USA) antibodies. Blots incubated without the primary antibodies were used as negative controls. IRDye 800CW-conjugated goat antirabbit antibody was used as the secondary antibody. The infrared fluorescent image was obtained using an Odyssey infrared imaging system (Li-Cor Bioscience, Lincoln, NE, USA).
Periodic acid-Schiff staining
Tissue sections were deparaffinized, rehydrated, and stained using the periodic acid-Schiff staining system (BASO DIAGNOSTICs INC., Taiwan) according to the instructions provided by the manufacturer.
RNA isolation and quantitative RT-PCR analysis
Total RNA was extracted from mouse embryonic tissues using TRIzol (Invitrogen, USA) according to the instructions provided by the manufacturer. Template cDNAs were obtained by reverse transcription of total RNAs using oligo-dT primers and superscript II reverse transcriptase (Invitrogen, USA). Amplification was carried out using SYBR Green QPCR Master Mix (Stratagene, USA). The expression level of b-actin was used as internal control. The sequences of the primers used were as follows: Adenovirus Ad-Arrb1-GFP (GFP-tagged b-arrestin 1 overexpression vector), Ad-Arrb2-GFP (GFP-tagged b-arrestin 2 overexpression vector) and Ad-GFP were produced, purified and titered as previously described (Shi et al., 2007; Zhang et al., 2010) . Viral stocks were stored at À80°C. Before cell infection, aliquots diluted in PBS with a 1.0 · 10 12 infectious particles per ml. The adenoviral vector Ad-GFP was used as the control.
4.7.
Lentivirus-mediated inhibition of b-arrestin 1 and b-arrestin 2
The recombinant lentivirus: LV-Arrb1-siRNA-GFP (GFP tagged b-arrestin 1-specific siRNA), LV-Arrb2-siRNA-GFP (GFP-tagged b-arrestin 2-specific siRNA) and LV-GFP were generated as described (Li et al., 2009) . Viruses were harvested and purified to yield titers of approximately 1.0 · 10 7 infectious particles per ml and stored at À80°C prior to cell infection. The lentiviral vector LV-GFP was used as the control.
Cell culture and virus infection
Mouse lung epithelium MLE-12 cells (a kind of gift from Dr. Wen Ning, Nankai University, China) were grown in DMEM:F12 = 1:1 (Gibco, USA). Mouse hepatoma Hepa 1-6 cells (CRL-1830, obtained from American Type Culture Collection) were maintained in DMEM (Gibco, USA). MLE-12 and Hepa 1-6 cells were infected with the recombinant adenovirus or lentivirus respectively. The cells were visualized using fluorescence microscopy and collected for quantitative RT-PCR or Western blot analysis. Ad-GFP adenovirus-infected and LV-GFP lentivirus-infected cells served as controls.
Statistical analysis
All results were analyzed with the Sigma plot 10.0 program (Systat Software). Data were presented as the mean ± s.e.m. Student's t-tests were used to compare two independent groups. Statistical significant was set as p < 0.05.
